UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma

Abstract Background Ubiquitin‐conjugating enzyme E2S (UBE2S), an E2 enzyme, is associated with the development of various tumors and exerts oncogenic activities. UBE2S is overexpressed in tumors, including hepatocellular carcinoma (HCC). However, the key molecular mechanisms of UBE2S in HCC still ne...

Full description

Bibliographic Details
Published in:	Cancer Medicine
Main Authors:	Junyi Wu, Xiangjie Xu, Shasha Wu, Weiwei Shi, Guang Zhang, Yin Cao, Zhongxia Wang, Junhua Wu, Chunping Jiang
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Subjects:	malignant properties sorafenib UBE2S VHL
Online Access:	https://doi.org/10.1002/cam4.6431

Similar Items

UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
by: Renyu Zhang, et al.
Published: (2024-10-01)

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition
by: Chengyu Li, et al.
Published: (2025-08-01)

UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma: Editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
by: Martina Mang Leng Lei, et al.
Published: (2025-01-01)

Clinical and Prognostic Value of VHL in Korean Patients with Rectal Cancer
by: Sang-Won Moon, et al.
Published: (2025-02-01)

Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL
by: Aileen Arevalo, et al.
Published: (2022-09-01)

MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma
by: Shouhua Zhang, et al.
Published: (2023-01-01)

VHL mutation as a cause of three generations familial pheochromocytoma
by: Mari Carmen Moran-Espinosa, et al.
Published: (2024-06-01)

Inhibition of VHL by VH298 Accelerates Pexophagy by Activation of HIF-1α in HeLa Cells
by: Yong Hwan Kim, et al.
Published: (2024-01-01)

Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
by: Renyu Zhang, et al.
Published: (2025-01-01)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
by: Joachim Albers, et al.
Published: (2013-04-01)

Loss of one copy of vhl in zebrafish facilitates hypoxia tolerance
by: Xueyi Sun, et al.
Published: (2023-12-01)

Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
by: Chong Li, et al.
Published: (2023-03-01)

Delayed Cardiac Metastasis from Renal Cell Carcinoma Caused by VHL Mutation
by: Christopher L. Sudduth, et al.
Published: (2023-02-01)

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India
by: Srilagna Chatterjee, et al.
Published: (2025-04-01)

Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases
by: Bicky Thapa, et al.
Published: (2024-11-01)

High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells
by: Songbiao Zhu, et al.
Published: (2022-08-01)

An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer
by: Artem V. Artemov, et al.
Published: (2022-08-01)

Control of Angiogenesis via a VHL/miR-212/132 Axis
by: Zhiyong Lei, et al.
Published: (2020-04-01)

Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01)

Trichostatin A destabilizes HIF-2α through a VHL-independent but proteasome-dependent pathway in cancer cell lines and tumor xenografts
by: Qingcheng Yang, et al.
Published: (2013-03-01)

Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch
by: Daisuke Aki, et al.
Published: (2018-11-01)

VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
by: Thomas Briston, et al.
Published: (2018-10-01)

NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1α degradation via SIRT1 inhibition
by: Hyun-Yoo Joo, et al.
Published: (2023-09-01)

Association of mutations and polymorphic variants of the VHL gene with the clinical characteristics of retinal capillary hemangioma
by: V. V. Neroev, et al.
Published: (2019-08-01)

SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC
by: Athina Ganner, et al.
Published: (2023-03-01)

VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line
by: Julia Felicitas Pilz, et al.
Published: (2024-01-01)

A case of ovarian mesothelioma with VHL mutation diagnosed by immunohistochemistry and literature review
by: Ye Yao, et al.
Published: (2024-11-01)

VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma
by: Lidija Todorović, et al.
Published: (2023-01-01)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
by: Xuechun Wang, et al.
Published: (2022-01-01)

Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways
by: Ligang Wang, et al.
Published: (2024-12-01)

Variants in the new E1ʹ cryptic exon of the VHL gene associated with congenital erythrocytosis—Description of three cases
by: Catarina Dantas Rodrigues, et al.
Published: (2022-08-01)

Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
by: Kousik Vankadari, et al.
Published: (2022-03-01)

VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function
by: Le Tong, et al.
Published: (2025-07-01)

Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma
by: Yonghong Man, et al.
Published: (2022-03-01)

Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the VHL 3′UTR in Gastric Cancer Cells
by: Xinglong Shi, et al.
Published: (2021-09-01)

MicroRNA profiling identifies VHL/HIF-2α dependent miR-2355-5p as a key modulator of clear cell Renal cell carcinoma tumor growth
by: Patric M. Page, et al.
Published: (2025-02-01)

Loss of Vhl alters trabecular bone loss during S. aureus osteomyelitis in a cell-specific manner
by: Caleb A. Ford, et al.
Published: (2022-09-01)

Case Report: von Hippel-Lindau (VHL) disease: a young female presenting with multiple organ tumors
by: Jingyuan Li, et al.
Published: (2025-10-01)

Radiogenomics and Texture Analysis to Detect von Hippel–Lindau (VHL) Mutation in Clear Cell Renal Cell Carcinoma
by: Federico Greco, et al.
Published: (2024-04-01)

Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
by: Federico Greco, et al.
Published: (2022-09-01)